One analysis of several hundred GLP-1 studies presented compelling evidence that they improve cognitive disorders, such as Alzheimers, substance-use disorders, such as alcohol, cocaine, and cannabis addiction, and mood and anxiety disorders, such as depression and bipolar disorder
Taking them both together may further raise your risk of gastrointestinal (GI) distress
Wang, L., Xu, R., Kaelber, D
Review of clinical trial data on Ozempic and hair loss Clinical data shows that about 0.80% of patients reported telogen effluvium or non-scarring hair loss within six months after starting Semaglutide at 0.25-2mg weekly doses [7]
Who is a good candidate for using semaglutide